April 23, 2020 / 12:23 PM / a month ago

BRIEF-Agilent Gets FDA Approval For Pd-L1 Companion Diagnostic On Dako Omnis

April 23 (Reuters) - Agilent Technologies Inc:

* AGILENT RECEIVES FDA APPROVAL FOR PD-L1 COMPANION DIAGNOSTIC ON DAKO OMNIS

* AGILENT TECHNOLOGIES INC - FDA APPROVED CO’S PD-L1 IHC 22C3 PHARMDX AS A COMPANION DIAGNOSTIC TO IDENTIFY PATIENTS WITH NON-SMALL CELL LUNG CANCER Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below